Pedro da Silva

Engineering Supervisor at Custom Pharma Services

Pedro Da Silva is an experienced Engineering Supervisor at Custom Pharmaceuticals Ltd since February 2003, responsible for maintaining manufacturing and plant equipment. Prior to this role, Pedro held positions as a Contract Engineer at both GlaxoSmithKline from January 1999 to February 2000 and Bodyshop in Littlehampton from December 1998 to January 2000. Educational qualifications include an HNC in Mechanical Engineering from North Brook College (2002-2004) and a BTEC First National Diploma in Mechanical Engineering from Lewes Tertiary College (1989-1991). Pedro's foundational education was completed at Cardinal Newman School from 1982 to 1989.

Location

Brighton, United Kingdom

Links


Org chart


Teams

This person is not in any teams


Offices


Custom Pharma Services

1 followers

Custom Pharma Services is located in Brighton, UK since 1979 and is a full-service contract development and manufacturing organisation (CDMO) providing services tailored to your needs, no matter how niche or complex. Custom covers the full spectrum of activities from development through commercial manufacturing for both clinical and commercial use. Specialising in Oral Solid Dosage forms with the ability to handle highly potent drugs and poorly bioavailable compounds Custom really is your one stop resource. With direct access to highly skilled experts offering a partnership approach Custom Pharma Services truly has a molecule first mentality, managing all projects with the end in mind. Custom Can! • Custom Pharma is a CDMO offering clinical and commercial manufacturing of tablets, capsules, powders (oral-solid-dose) for human use. • Services comprise pre-formulation and formulation development, analytical development, stability testing, clinical trial material manufacturing • Commercial Production • Pre-clinical formulation development and solubilisation • Material characterisation • Drug in capsule approach to accelerate early clinical studies • Specialists in low dosage (sub-mg) formulations • Contained manufacturing for highly potent APIs • Orphan drug development • Formulation development of poorly soluble drugs, including spray drying capabilities


Employees

51-200

Links